Bone morphogenetic protein-2/4 and bone morphogenetic protein receptor type IA expression in metastatic and nonmetastatic oral squamous cell carcinoma

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 31, Issue 4, 2010, Pages 266-271

  Soares, Andréa Ferreira ^a   Xavier, Ruth Lopes de Freitas ^a   da Costa Miguel, Márcia Cristina ^a   de Souza, Lélia Batista ^a   Pinto, Leão Pereira ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; METASTASIS; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE COURSE; METABOLISM; MOUTH TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SECONDARY;

BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 77953958761     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2009.03.002     Document Type: Article

References (26)

1. Balemans W., and Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250 (2002) 231-250
2. Whitman M. Smads and early developmental signaling by the TGF-beta superfamily. Genes Dev 12 (1998) 2445-2462
3. Botchkarev V.A., Botchkareva N.V., Sharov A.A., et al. Modulation of BMP signaling by noggin is required for induction of the secondary (nontylotrich) hair follicles. J Invest Dermatol 118 (2002) 3-10
4. Hsu M.Y., Rovinsky S., Penmatcha S., et al. Bone morphogenetic proteins in melanoma: angel or devil?. Cancer Metastasis Rev 24 (2005) 251-263
5. Niculescu III A.B., Chen X., Smeets M., et al. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 18 (1998) 629-643
6. Derynck R., Akhurst R.J., and Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 29 (2001) 117-129
7. Janda E., Lehmann K., Killisch I., et al. Ras and TGF-β cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 156 (2002) 299-313
8. Levy L., and Hill C. Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 17 (2006) 41-58
9. Wakulich C., Jackson-Boeters L., Daley T.D., et al. Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor-2 and fibroblast growth factor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol 93 (2002) 573-579
10. Langenfeld E.M., Bojnowski J., Perone J., et al. Expression of bone morphogenetic proteins in human lung carcinomas. Ann Thorac Surg 80 (2005) 1028-1032
11. Jin Y., Tipoe G.L., Liong E.C., et al. Overexpression of BMP-2/4, -5 and BMPR-IA associated with malignancy of oral epithelium. Oral Oncol 37 (2001) 225-233
12. Kusafuka K., Yamaguchi A., Kayano T., et al. Expression of bone morphogenetic proteins in salivary pleomorphic adenomas. Virchows Arch 432 (1998) 247-253
13. Schwalbe M., Sänger J., Eggers R., et al. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer. Int J Oncol 23 (2003) 89-95
14. Yoshikawa H., Nakase T., Myoui A., et al. Bone morphogenetic proteins in bone tumors. J Orthop Sci 9 (2004) 334-340
15. Kumamoto H., and Ooya K. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors. Oral Dis 12 (2006) 163-170
16. Hardwick J.C., Van Den Brink G.R., Bleuming S.A., et al. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 126 (2004) 111-121
17. Kim I.Y., Lee D.H., Ahn H.J., et al. Expression of bone morphogenetic protein receptors type-IA, -IB, and II correlates with tumor grade in human prostate cancer tissues. Cancer Res 60 (2000) 2840-2844
18. Kim I.Y., Lee D.H., Lee D.K., et al. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1. Cancer Res 64 (2004) 7355-7360
19. Langenfeld E.M., and Langenfeld J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2 (2004) 141-149
20. Arnold S.F., Tims E., and McGrath B.E. Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP-2. Cytokine 11 (1999) 1031-1037
21. Kawamura C., Kizaki M., Yamato K., et al. Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood 96 (2000) 2005-2011
22. Hjertner O., Hjorth-Hansen H., Börset M., et al. Bone morphogenetic protein-4 proliferation and induces apoptosis of multiple myeloma cells. Blood 97 (2001) 516-522
23. Wen X.Z., Miyake S., Akiyama Y., et al. BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. Biochem Biophys Res Commun 316 (2004) 100-106
24. Kim I.Y., and Kim S.J. Role of bone morphogenetic proteins in transitional cell carcinoma cells. Cancer Letters 241 (2006) 118-123
25. Pouliot F., Blais A., and Labrie C. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. Cancer Res 63 (2003) 277-281
26. Raida M., Clement J.H., Leek R.D., et al. Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol 131 (2005) 741-750